Journals / Turkish Journal of Medical Sciences / 2016 / Cilt: 46 - Sayı: 5

Effects of crocin on experimental obesity and type-2 diabetes

Pages
1593–1602
Publication Date
2022-11-03
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Similarly, it was found that oxidative stress, which increased due to the progress of diabetes, was reduced in crocin treatment group.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: The aim of this study is to scrutinize the effects of crocin on obesity and type-2 diabetes, with an approach that takes oxidative stress and inflammatory parameters into account.
📊
Key Findings & Data:Materials and methods: The experimental obesity model was created by utilizing a 10-week-long high-fat diet (HFD).
💡
Conclusion & Impact:Similarly, it was found that oxidative stress, which increased due to the progress of diabetes, was reduced in crocin treatment group.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: The aim of this study is to scrutinize the effects of crocin on obesity and type-2 diabetes, with an approach that takes oxidative stress and inflammatory parameters into account. Materials and methods: The experimental obesity model was created by utilizing a 10-week-long high-fat diet (HFD). An experimental type-2 diabetes model was created by injecting multiple low-dose streptozocin (STZ) injections into rats that were fed with the HFD. The treatment groups were administered a daily crocin dose of 150 mg/kg for 6 weeks via gavage. Results: Findings of the study demonstrated that crocin could be effective in relieving the symptoms of obesity and diabetes (hyperinsulinemia, hyperleptinemia, insulin resistance, and weight gain). It was determined that crocin lowered the plasma TNF-α and IL-1β levels and the pancreas tissue TNF-α and IFN-γ levels, which were increased due to diabetes, and reduced the inflammation in diabetic rats. Similarly, it was found that oxidative stress, which increased due to the progress of diabetes, was reduced in crocin treatment group. Conclusion: Crocin could contribute to the development of phytotherapeutic approaches in the treatment of obesity, diabetes, and diabesity (obesity-induced diabetes), which is promising as the abovementioned incidences have increased considerably in today s world.

🔖

Cite This Article

AKSOY, L., HAZMAN, Ö., BÜYÜKBEN, A. (2022). Effects of crocin on experimental obesity and type-2 diabetes. Turkish Journal of Medical Sciences, Cilt: 46 - Sayı: 5, 1593–1602. https://ajindex.com/articles/610777

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. OECD. Obesity Update 2014. An Organisation for Economic Co-operation and Development (OECD) Report. Paris, Frace: OECD; 2014
  2. IDF. Diabetes Atlas, 6th ed. Brussels, Belgium: International Diabetes Federation; 2013
  3. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukav S, Abbafati C, Abera SF et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 766-781
  4. Hussain A, Hydrie MZI, Claussen B, Asghar S. Type 2 Diabetes and obesity: a review. Journal of Diabetology 2010; 2: 1-7
  5. Bastard JP, Jardel C, Bruckert E, Biondy P, Capeau J, Laville M, Vidal H, Hainque B. Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000; 85: 3338-3342
  6. Singla P, Bardoloi A, Parkash AA. Metabolic effects of obesity: a review. World J Diabetes 2010; 1: 76-88
  7. Kopelman PG. Obesity as a medical problem. Nature 2000; 404: 635-643
  8. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 1: 4-12
  9. Khan NI, Naz L, Yasmeen G. Obesity: an independent risk factor for systemic oxidative stress. Pak J Pharm Sci 2006; 19: 62-65
  10. Robertson RP, Harmon J, Tran PO, Poitout V. β-Cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 2004; 53: 119-124
  11. Hazman Ö, Ovalı S. Investigation of the anti-inflammatory effects of safranal on high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Inflammation 2015; 38: 1012-1019
  12. Maritim AC, Sanders RA, Watkins JB. Diabetes, oxidative stress and antioxidants: review. J Biochem Mol Toxicol 2003; 17: 4-38
  13. Gallic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010; 316: 129-139
  14. Pham TQ, Cormier F, Farnworth E, Tong VH, Van Calsteren MR. Antioxidant properties of crocin from Gardenia jasminoides Ellis and study of the reactions of crocin with linoleic acid and crocin with oxygen. J Agric Food Chem 2000; 48: 1455-1461
  15. Kyriakides ML, Kyriakidis DA. Crocus sativus biological active constituents. Studies Nat Prod Chem 2002; 26: 293-312
  16. Sánchez AM, Carmona M, Jarén-Galán M, Mosquera MI, Alonso GL. Picrocrocin